tradingkey.logo
tradingkey.logo

US FDA approves Denali's genetic disorder therapy

ReutersMar 25, 2026 3:41 PM

- The U.S. Food and Drug Administration has approved Denali Therapeutics' DNLI.O therapy for a rare genetic disorder, the regulator said on Wednesday.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI